StockNews.AI

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

StockNews.AI • 1 minute

PEN
High Materiality8/10

Information

BALA CYNWYD, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi...

Original source

AI Summary

Boston Scientific (BSX) is set to acquire Penumbra, Inc. for $374 per share, amounting to an enterprise value of roughly $14.5 billion. However, an ongoing investigation probes the Penumbra Board's adherence to fiduciary duties, potentially questioning the fairness of the transaction.

Sentiment Rationale

Historically, acquisitions can positively influence stock prices as synergies and growth prospects are realized; however, uncertainties from investigations can create volatility.

Trading Thesis

Given current conditions, BSX could see a moderate to bullish upside post-acquisition closure.

Market-Moving

  • Investigation outcomes may influence the completion timeline of the Penumbra acquisition.
  • Shareholder reactions could affect BSX's stock price leading up to the deal's closure.
  • Potential alterations in acquisition terms could sway investor sentiment and BSX’s value.

Key Facts

  • Boston Scientific to acquire Penumbra for $374 per share.
  • The deal values Penumbra at approximately $14.5 billion.
  • An investigation is underway regarding Penumbra Board's fiduciary duties.
  • Questions arise about whether the deal provides fair value to shareholders.

Companies Mentioned

  • Boston Scientific Corporation (BSX): Acquisition of Penumbra may enhance BSX’s market position.
  • Penumbra, Inc. (PEN): Pending investigation could delay acquisition and impact BSX’s valuation.

M&A

The article fits the 'M&A' category, focusing on the impact of a significant acquisition by BSX that is also subject to scrutiny. This situation could affect BSX's stock as investors assess the fairness of the deal amidst ongoing investigations.

Brodsky & Smith Shareholder Update: Investigations into Recent Acquisitions

BALA CYNWYD, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) — Brodsky & Smith is currently investigating several companies following recent merger agreements. These inquiries are aimed at determining whether the respective boards have acted in the best interests of their shareholders. If you hold shares in any of the companies mentioned and wish to discuss the situation, please contact Jason Brodsky at jbrodsky@brodskysmith.com or Marc Ackerman at mackerman@brodskysmith.com, or call 855-576-4847. There is no cost or financial obligation for shareholders to take part in this investigation.

Penumbra, Inc. (NYSE: PEN) Acquisition by Boston Scientific (BSX)

Under the recent merger agreement, Penumbra, Inc. will be acquired by Boston Scientific Corporation (NYSE: BSX) in a blended cash and stock deal valued at $374 per share. This acquisition reflects an enterprise value of approximately $14.5 billion.

The investigation will focus on whether the Penumbra Board breached its fiduciary duties by failing to ensure a fair process and whether the offered deal consideration reflects fair value for shareholders. Additional information can be found on the Brodsky & Smith website.

Calavo Growers, Inc. (NASDAQ: CVGW) Acquired by Mission Produce

Calavo Growers is set to be acquired by Mission Produce, Inc. (NASDAQ: AVO) as per the details of their merger agreement. Under the terms, Calavo shareholders will receive a total of $27.00 per share, comprising $14.85 in cash and 0.9790 shares of Mission stock for each share of Calavo owned. This transaction results in a total enterprise value of around $430 million.

Post-merger, Mission shareholders are expected to hold approximately 80.3% of the combined entity, with Calavo shareholders retaining 19.7%. The investigation will examine if the Calavo Board fulfilled its fiduciary responsibilities adequately. More details can be accessed on the Brodsky & Smith website.

Clearwater Analytics Holdings, Inc. (NYSE: CWAN) Acquisition Details

Clearwater Analytics is being acquired by a Permira and Warburg Pincus-led investor group for $24.55 per share in cash, translating to an approximate transaction value of $8.4 billion.

This investigation will determine if the Clearwater Analytics Board acted in good faith and whether they provided a fair process concerning the deal and its implications for shareholders. For more information, please visit the Brodsky & Smith website.

Brodsky & Smith is a litigation law firm specializing in representing shareholders in securities class action lawsuits. The firm's attorneys have successfully recovered millions of dollars on behalf of investors and have been appointed by various courts nationwide as lead counsel. Please note that prior results do not guarantee a similar outcome.

Related News